January 26, 2023
Aspiring to deliver new cures for complex conditions
Mayo Clinic is building toward a future when biologics can cure cancer, kidney disease and diabetes. Mayo marks 2022 as a year of significant strides in accelerating science to make and deliver regenerative biotherapeutics. The goal is to offer new options, based on rigorous research in cell and gene therapies, for disorders with few available […]
Tags: 3D bioprinting, biologics, biomanufacturing, CAR-T cell therapy, Center for Regenerative Biotherapeutics, Julie Allickson, purified exosome product, stromal vascular fraction cells, tissue engineering
November 14, 2022
A step toward a cell-free solution for stress urinary incontinence
Skeletal muscle regenerated and symptoms of stress urinary incontinence improved in preclinical models after use of a cell-free product discovered at Mayo Clinic. In one of the first studies of its kind, Mayo Clinic researchers learned this noncellular approach can restore muscle function and bladder control in preclinical models. The teams of Atta Behfar, M.D., […]
Tags: Atta Behfar, Center for Regenerative Biotherapeutics, Emanuel Trabuco, purified exosome product, stress urinary incontinence